Next report date
Report period
Q1 2024
EPS estimate
−0.49MXN
Revenue estimate
—
−1.10MXN
−62.86 MMXN
50.76 M
About ORYZON GENOMICS, S.A.
Sector
Industry
CEO
Carlos Manuel Buesa Arjol
Website
Headquarters
Barcelona
Founded
2000
ISIN
ES0167733015
FIGI
BBG00ZCWWLP9
Oryzon Genomics SA is a clinical stage biopharmaceutical company, which engages in the discovery, research, and development of new chemical entities, as well as conducting clinical trials. It focuses on epigenetics in various therapeutic indications, with a special emphasis on oncology and neurodegenerative disease. The firm's product pipelines include Iadademstat and Vafidemstat. The company was founded by Carlos Manuel Buesa Arjol and Tamara Maes on June 2, 2000 and is headquartered in Barcelona, Spain.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ORY/N is 48.59 MXN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange ORYZON GENOMICS SA stocks are traded under the ticker ORY/N.
ORYZON GENOMICS SA is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
ORY/N stock is 0% volatile and has beta coefficient of 0.25. Check out the list of the most volatile stocks — is ORYZON GENOMICS SA there?
ORY/N earnings for the last quarter are −0.35 MXN per share, whereas the estimation was −0.77 MXN resulting in a 55.04% surprise. The estimated earnings for the next quarter are −0.97 MXN per share. See more details about ORYZON GENOMICS SA earnings.
Yes, you can track ORYZON GENOMICS SA financials in yearly and quarterly reports right on TradingView.
ORY/N net income for the last quarter is −32.29 M MXN, while the quarter before that showed −19.57 M MXN of net income which accounts for −64.97% change. Track more ORYZON GENOMICS SA financial stats to get the full picture.
Today ORYZON GENOMICS SA has the market capitalization of 2.27 B, it has increased by 5.07% over the last week.
No, ORY/N doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ORY/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORYZON GENOMICS SA stock right from TradingView charts — choose your broker and connect to your account.
We've gathered analysts' opinions on ORYZON GENOMICS SA future price: according to them, ORY/N price has a max estimate of 218.55 MXN and a min estimate of 45.53 MXN. Read a more detailed ORYZON GENOMICS SA forecast: see what analysts think of ORYZON GENOMICS SA and suggest that you do with its stocks.